Frontlight ResearchEarly access
Trial site
Zaporizhzhya
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Chronic kidney disease2 trials
- Atrial fibrillation1 trial
- Diffuse large B-cell lymphoma1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Lupus (SLE)1 trial
- Multiple sclerosis1 trial
- Ovarian cancer1 trial
- Sarcoma1 trial
- Type 2 diabetes1 trial
- Ventricular tachycardia1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Status
- Active, not recruiting8 trials
- Terminated3 trials
- Recruiting1 trial
- Lead sponsor
- AstraZeneca10 trials
- Acerta Pharma BV1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
Running trials
Active, not recruiting
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Terminated
Terminated
Terminated
A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis
Site data: ClinicalTrials.govUpdated 12 Nov 2026